H pylori eradication
Diagnostic Testh.pylori stool antigen
NCT Number: NCT07293169
* Helicobacter pylori (H. pylori) infection affects approximately one half of the world population and it is more prevalent in developing countries. This microorganism colonizes the stomach. Typically, it is acquired during childhood and causes asymptomatic chronic infection. A small portion of H. pylori infected subjects develop peptic ulcers and gastric carcinoma, usually during late adulthood. (1,2) * Some studies show a relationship between H.pylori and pregnancy-related disorders, such as fetal growth defects and malformations, miscarriage and, more recently, to pre-eclampsia. (3) * Abortion is one of the most common complications of pregnancy. Infection is one of the main causes of abortion, a cause which is more important in spontaneous abortion; infections account for only 5% of recurrent abortions. (4) * The severity of infection with H.pylori: given the increasing secretion of inflammatory cytokines and CD8 +, CD4 + in T cells and increasing interferons (IFN), studies have shown that infection with Helicobacter pylori activates immune cells in the uterus and endometrial surface cells, increases TH1 response to helicobacter, disturbs the ratio of T-Helper 2 / T-Helper 1 cytokines, causes abnormalities in the formation of natural vessels in the uterus and, ultimately, leads to abortion.(5) * Repeated spontaneous abortion (RSA): >=2 consecutive spontaneous pregnancy losses before 20 weeks gestation.(6) * To determine if H.pylori infection is significantly associated with recurrent abortion of unknown cause........
Trial opening soon.
Get NotifiedFemale
Observational
3.Patients and methods
Study design:
Case Control study two groups (one group of 50 women with history of recurrent abortion and another group of 50 women without recurrent of abortion)
Study location:
the study will be conducted in Assiut university hospitals (women's health hospital) .
Study duration:
the study will be carried out from October 2025 till October 2026.
Sample size :
the calculated sample size for two groups 100 cases (one group of 50 women with history of recurrent abortion and another group of 50 women without recurrent of abortion).
4.Inclusion criteria
5.Exclusion criteria
7.All patients will be subjected to the following
H.pylori antigen in stool ,complete blood count , abdominopelvic ultrasound , urine analysis , liver and kidney function tests ,TSH , prolactin and any necessary investigation will be done.
Anti cardiolipin (IgM , IgG) ,Lupus anti coagulant and Anti B2 glycoproteinA1 (IgM, IgG) and 3D US on uterus . 8.Ethical considerations
9.Statistical analysis
10.References
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
• All woman with repeated abortion of Unknwon cause.
Exclusion criteria
h.pylori stool antigen
Time frame: baseline
Time frame: the study will be carried out from October 2025 till October 2026
Contact information is provided by the study sponsor or research team.
Hanan Mohamed Nafeh assiut
CONTACT
Mostafa Gamal Ahmed Mostafa موشا -مركز اسيوط -محافظة اسيوط
CONTACT
01095773806 ext. 01095773806
Assiut University
Other
H.Pylori Infection Among Women With Recurrent Abortion of Unknown Cause
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05410652
Fecal Drug Resistance Gene Detection, Helicobacter Pylori Infection
Nanjing, Jiangsu, China
View Trial DetailsNCT05863858
Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to
Karachi, Sindh, Pakistan
View Trial DetailsNCT05247112
Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation, Helicobacter Pylori Associated Gastrointestinal Disease
Seongnam-si, Gyeonggi-do, South Korea
View Trial Details